Stryker Corporation Orthopaedics (revenue)
Orthopaedics (revenue) at Stryker Corporation came to $2.9B for the quarter to 30 Sep 2026, up 5.7% from a year earlier.
As Stryker Corporation reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.
By quarter
| Period ending | Orthopaedics (revenue) | Change on a year | Filed |
|---|---|---|---|
| 30 Sep 2026 | $2.9B | up 5.7% | 30 Oct 2026 |
| 30 Jun 2026 | $3.0B | up 9.1% | 26 Jun 2026 |
| 31 Mar 2026 | $2.8B | up 0.1% | 11 May 2026 |
| 31 Dec 2025 | $3.2B | — | 11 Feb 2026 |
| 30 Sep 2025 | $2.7B | — | 31 Oct 2025 |
| 30 Jun 2025 | $2.7B | — | 1 Aug 2025 |
| 31 Mar 2025 | $2.8B | — | 2 May 2025 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Stryker Corporation: Organic net sales (change on a year) · Neuro Cranial Instruments revenue · Orthopaedic Instruments revenue · Neuro Cranial - Interventional Spine revenue · Enabling Technologies revenue · Medical revenue · Endoscopy revenue · Trauma and Extremities revenue · Instruments revenue · Instruments (earlier basis) revenue · Ortho Tech revenue · Neuro Cranial revenue · Knees revenue · Vascular revenue · Hips revenue · Spinal Implants revenue · MedSurg and Neurotechnology (revenue) · United States revenue · Europe, Middle East, Africa revenue · Asia Pacific revenue · International revenue · financial statements
Every KPI and segment of SYK, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
